5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study

Use of 5-Alpha-Reductase Inhibitors Did Not Increase the Risk of Cardiovascular Diseases in Patients with Benign Prostate Hyperplasia: A Five-Year Follow-Up Study

(2015) Teng-Fu Hsieh et al.   PLoS One

Zolpidem and the risk of Parkinson's disease: A nationwide population-based study

(2014) Yu-Wan Yang et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Current medical treatment of lower urinary tract symptoms/BPH

(2013) João Silva et al.   CURRENT OPINION IN UROLOGY

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

(2013) Matthias Oelke et al.   EUROPEAN UROLOGY

Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients

(2013) Xiaobing Qu et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Testosterone and insulin resistance in the metabolic syndrome and T2DM in men

(2013) Preethi M. Rao et al.   Nature Reviews Endocrinology

The Prevalence and Predictors of Androgen Deficiency in Taiwanese Men With Type 2 Diabetes

(2013) Rue-Tsuan Liu et al.   UROLOGY

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

(2012) Chun-Ying Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

(2012) Neil E Fleshner et al.   LANCET

Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

(2011) J. Curtis Nickel et al.   BJU INTERNATIONAL

Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels

(2011) Won Tae Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

(2011) Kevin T. McVary et al.   JOURNAL OF UROLOGY

Diabetes and prostate cancer risk in the REDUCE trial

(2011) C Wu et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Insomnia medication: Do published studies reflect the complete picture of efficacy and safety?

(2010) Taina Mattila et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

(2010) Y Niu et al.   ONCOGENE

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

(2010) Ching-Lan Cheng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sudden Sensorineural Hearing Loss Increases the Risk of Stroke

(2008) Herng-Ching Lin et al.   STROKE